IBM has launched the Watson for Cyber Security beta program to encourage companies to include Watson in their current security environments. Starting off with such organizations as California Polytechnic State University, Sumitomo Mitsui Banking Corporation, and University of Rochester Medical Center, the program will grow over the next few weeks to encompass 40 companies spanning industries like banking, travel, energy, automotive, health care, insurance, and education. For the past few months, IBM Security has been working with eight universities -- California State Polytechnic University at Pomona, Penn State, MIT, New York University, University of Maryland at Baltimore County, and Canada's universities of New Brunswick, Ottawa, and Waterloo -- to help teach Watson the "language of cybersecurity." The research project involved feeding Watson's AI brain thousands of documents annotated to help the system understand what a threat is, what it does, and what indicators are related. Watson for Cyber Security combines machine learning and natural language processing to make associations in unstructured data like blogs, research reports, and documentation that security analysts can then use to make better, faster decisions.

You may know Watson as IBM's Jeopardy-winning, cookbook-writing, dress-designing, weather-predicting supercomputer-of-all trades. Starting today, 40 organizations will rely upon the clever computers cognitive power to help spot cybercrime. The Watson for Cybersecurity beta program helps IBM too, because Watson's real-world experience will help it hone its skills and work within specific industries. After all, the threats that keep security experts at Sun Life Financial up at night differ from those that spook the cybersleuths at University of New Brunswick. IBM researchers started training Watson in the fundamentals of cybersecurity last spring so the computer could begin to analysize and prevent threats.

MoneyLion secures $22.5M to bring fresh talent to AI finance management Stay up-to-date on the topics you care about. We'll send you an email alert whenever a news article matches your alert term. It's free, and you can add new alerts at any time.

For this tutorial, we're going to power TJBot with APIs from Watson Developer Cloud. We'll start by putting a voice interface onto TJBot, then give it the ability to converse and understand your emotional tones. In part 2 of the tutorial, we'll transfer the code onto a Raspberry Pi and put the whole thing into the physical TJBot itself. For the sake of simplicity, we'll keep the conversation simple.

IBM Watson's AI is trying to find new cancer treatments IBM continued Watson's evolution on Thursday when the computing company announced it will use the artificial intelligence system to seek out new treatments for cancer patients. The plan also includes a partnership with drug-maker Pfizer, and for good reason: It will be one of the first companies to use Watson for drug research and the first to customize the A.I. for its own purposes. Pfizer will use Watson to "support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology." This collaboration is part of IBM's efforts to use Watson as a medical tool. The company said that the A.I. has "ingested" more than 1 million articles from medical journals, 4 million patents, and 25 million abstracts from Medline, a medical supplies manufacturer and distributor.

You may know Watson as IBM's Jeopardy-winning, cookbook-writing, dress-designing, weather-predicting supercomputer-of-all trades. Starting today, 40 organizations will rely upon the clever computers cognitive power to help spot cybercrime. The Watson for Cybersecurity beta program helps IBM too, because Watson's real-world experience will help it hone its skills and work within specific industries. After all, the threats that keep security experts at Sun Life Financial up at night differ from those that spook the cybersleuths at University of New Brunswick. IBM researchers started training Watson in the fundamentals of cybersecurity last spring so the computer could begin to analysize and prevent threats.

Want to watch this again later? Report Need to report the video? Report Need to report the video? Need to report the video? This feature is not available right now.

Want to watch this again later? Report Need to report the video? Report Need to report the video? Need to report the video? This feature is not available right now.

HARMAN participated at IBM's World of Watson event in Las Vegas to announce how we are integrating the cognitive technology capabilities of IBM Watson with HARMAN's powerful enterprise IOT solutions. Drawing on our extensive enterprise IOT solutions, HARMAN is providing the'central nervous system' to the IBM Watson'brain' for more intuitive, connected experiences in healthcare, hospitality and corporate settings. The result: voice enabled cognitive rooms by HARMAN. Mohit Parasher, executive vice president and president, Professional Solutions at HARMAN, participated on stage to discuss how HARMAN and IBM successfully tested a prototype voice-activated JBL speaker solution at Thomson Jefferson University Hospital in Philadelphia that allows patients to control their environment directly and answer questions with the goal of improving patient experiences and care. Eighty percent of physicians describe themselves as overextended or at capacity.

IBM's Deborah DiSanzo made the announcement at the 2016 Forbes Healthcare Summit. Immunotherapy is an approach that uses the immune system to fight diseases, unlike chemotherapy, which kills cancer cells. Immunotherapy works on cells in the immune system to combat cancer. Dario Gil, director of symbiotic cognitive systems at IBM Research, holds a remote control wand while giving a demonstration of the IBM Watson immersion room during an event at the company's headquarters in New York Oct. 7, 2014. By partnering with IBM's Watson for Drug Discovery, Pfizer hopes to more quickly analyze and test hypotheses from "massive volumes of disparate data sources" that include more than 30 million sources of laboratory and data reports as well as medical literature.